APA (7th ed.) Citation

Barberio, B., Todeschini, A., Laterza, L., Viola, A., Bezzio, C., Mendolaro, M., . . . Principi, M. B. (2026). MIRACLE-UC: Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in Patients with Ulcerative Colitis - A Multicenter Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD). Journal of Crohn's & Colitis, 20, i1625.

Chicago Style (17th ed.) Citation

Barberio, B., et al. "MIRACLE-UC: Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in Patients with Ulcerative Colitis - A Multicenter Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)." Journal of Crohn's & Colitis 20 (2026): i1625.

MLA (9th ed.) Citation

Barberio, B., et al. "MIRACLE-UC: Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in Patients with Ulcerative Colitis - A Multicenter Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)." Journal of Crohn's & Colitis, vol. 20, 2026, p. i1625.